logo
AAT Bioquest

Amplite® Fluorimetric Glucose-6-Phosphate Dehydrogenase (G6PD) Assay Kit

G6PD dose response was measured with Amplite® Fluorimetric Glucose-6-Phosphate Dehydrogenase Assay Kit in a 96-well solid black plate using a Gemini (Molecular Devices) microplate reader. The concentration of the  Glucose-6-Phosphate Dehydrogenase in X-axis is based on the 50 uL standard, the final in-well concentration should be 1/2 for each point.
G6PD dose response was measured with Amplite® Fluorimetric Glucose-6-Phosphate Dehydrogenase Assay Kit in a 96-well solid black plate using a Gemini (Molecular Devices) microplate reader. The concentration of the  Glucose-6-Phosphate Dehydrogenase in X-axis is based on the 50 uL standard, the final in-well concentration should be 1/2 for each point.
G6PD dose response was measured with Amplite® Fluorimetric Glucose-6-Phosphate Dehydrogenase Assay Kit in a 96-well solid black plate using a Gemini (Molecular Devices) microplate reader. The concentration of the  Glucose-6-Phosphate Dehydrogenase in X-axis is based on the 50 uL standard, the final in-well concentration should be 1/2 for each point.
Ordering information
Price
Catalog Number
Unit Size
Quantity
Add to cart
Additional ordering information
Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
ShippingStandard overnight for United States, inquire for international
Request quotation
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
UNSPSC12352200

OverviewpdfSDSpdfProtocol


Glucose-6-phosphate dehydrogenase (G6PD) catalyzes the conversion of glucose-6-phosphate to 6-phosphoglucono-δ-lactone, the first and rate-limiting step in the pentose phosphate pathway. It is critical metabolic pathway that supplies reducing energy to cells (such as erythrocytes) by maintaining the level of co-enzyme nicotinamide adenine dinucleotide phosphate (NADPH), and for the production of pentose sugars. The production of NADPH is of great importance for tissues actively engaged in biosynthesis of fatty acids and/or isoprenoids, such as the liver, mammary glands, adipose tissue, and the adrenal glands. The NADPH also maintains the level of glutathione in these cells that helps protect the red blood cells against oxidative damage. Deficiencies in G6PD predispose individuals to non-immune hemolytic anemia. AAT Bioquest's Amplite® Fluorimetric Glucose-6-Phosphate Dehydrogenase Assay Kit provides a simple, sensitive and rapid fluorescence-based method for detecting G6PD in biological samples such as serum, plasma, urine, as well as in cell culture samples. In the enzyme coupled assay, G6PD activity is proportionally related to the concentration of NADPH that is specifically monitored by a fluorogenic NADPH sensor to yield a highly red fluorescence product. The fluorescence signal can be read with a fluorescence microplate reader. With the G6PD assay kit, we were able to detect as little as 1 mU/ml G6PD in a 100 µL reaction volume.

Platform


Fluorescence microplate reader

Excitation540 nm
Emission590 nm
Cutoff570 nm
Recommended plateSolid black

Components


Example protocol


AT A GLANCE

Protocol Summary
  1. Prepare G6PD standards or test samples (50 µL)
  2. Add G6PD working solution (50 µL)
  3. Incubate at RT for 30 minutes - 2 hours
  4. Monitor fluorescence increase at Ex/Em = 540/590 nm 
Important      Thaw each kit component at room temperature before starting the experiment.

PREPARATION OF STOCK SOLUTIONS

Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles.

1. NADP stock solution (100X)
Add 100 µL of H2O into the vial of NADP (Component C) to make 100X NADP stock solution.

2. G6PD standard solution (100 U/mL)
Add 100 µL of H2O or 1X PBS buffer into the vial of G6PD Standard (Component D) to make 100 U/mL G6PD standard solution.

PREPARATION OF STANDARD SOLUTION

For convenience, use the Serial Dilution Planner:
https://www.aatbio.com/tools/serial-dilution/13806


G6PD standard
Add 10 µL of G6PD standard solution into 990 µL 1X PBS buffer to generate 1000 mU/mL G6PD standard solution. Take 15 µL of 1000 mU/mL G6PD standard solution into 485 uL of 1X PBS buffer to generate 30 mU/mL G6PD (G6PD7), and then perform 1:3 serial dilutions to get serial dilutions of G6PD standard (G6PD6 - G6PD1). Note: Diluted G6PD standard solution is unstable, and should be used within 4 hours.

PREPARATION OF WORKING SOLUTION

Add 5 mL of Assay Buffer (Component B) into one bottle of Enzyme Probe (Component A). Add 50 µL NADP stock solution (100X) into the bottle of Component A, and mix well.
Note     This G6PD assay working solution is enough for one 96-well plate.

SAMPLE EXPERIMENTAL PROTOCOL

Table 1. Layout of G6PD standards and test samples in a solid black 96-well microplate. G6PD = D-Glucose-6-Phosphate Dehydrogenase standard (G6PD1 - G6PD7, 0.04 to 30 mU/mL); BL = blank control; TS = test samples.
BLBLTSTS
G6PD1G6PD1......
G6PD2G6PD2......
G6PD3G6PD3
G6PD4G6PD4
G6PD5G6PD5
G6PD6G6PD6
G6PD7G6PD7
Table 2. Reagent Composition for each well.
WellVolumeReagent
G6PD1 -
G6PD7
50 µLSerial Dilution (0.04 to 30 mU/mL)
BL50 µLDilution Buffer (PBS)
TS50 µLTest Sample
  1. Prepare G6PD standards (G6PD), blank controls (BL), and test samples (TS) according to the layout provided in Table 1 and Table 2. For a 384-well plate, use 25 µL of reagent per well instead of 50 µL.
  2. Add 50 µL of G6PD working solution to each well of G6PD standard, blank control, and test samples to make the total assay volume of 100 µL/well. For a 384-well plate, add 25 µL of working solution into each well instead, for a total volume of 50 µL/well.
  3. Incubate the reaction at room temperature for 30 minutes to 2 hours, protected from light.
  4. Monitor the fluorescence increase with a fluorescence plate reader at Ex/Em = 540/590 nm, cut off at 570 nm. 

Images


Citations


View all 1 citations: Citation Explorer
A novel pathogenic variant in the glucokinase gene found in two Japanese siblings with maturity-onset diabetes of the young 2
Authors: Tanaka, Satoshi and Akagawa, Hiroyuki and Azuma, Kenkou and Watanabe, Kaoru and Higuchi, Sayaka and Iwasaki, Naoko
Journal: Endocrine Journal (2023): EJ22--0541

References


View all 71 references: Citation Explorer
The microsomal enzyme 17beta-hydroxysteroid dehydrogenase 3 faces the cytoplasm and uses NADPH generated by glucose-6-phosphate dehydrogenase
Authors: Legeza B, Balazs Z, Nashev LG, Odermatt A.
Journal: Endocrinology (2013): 205
Molecular characterization of glucose-6-phosphate dehydrogenase deficient variants in Baghdad city - Iraq
Authors: Al-Musawi BM, Al-Allawi N, Abdul-Majeed BA, Eissa AA, Jubrael JM, Hamamy H.
Journal: BMC Blood Disord (2012): 4
High prevalence of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa)
Authors: Millimono TS, Loua KM, Rath SL, Relvas L, Bento C, Diakite M, Jarvis M, Daries N, Ribeiro LM, Manco L, Kaeda JS.
Journal: Hemoglobin (2012): 25
Effects of laparoscopic Roux-en-Y gastric bypass on glucose-6 phosphate dehydrogenase activity in obese type 2 diabetics
Authors: Schneider AM, Rawat D, Weinstein LS, Gupte SA, Richards WO.
Journal: Surg Endosc (2012): 823
A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency
Authors: Shah SS, Diakite SA, Traore K, Diakite M, Kwiatkowski DP, Rockett KA, Wellems TE, Fairhurst RM.
Journal: Sci Rep (2012): 299
Effects of glucose-6-phosphate dehydrogenase deficiency on the metabolic and cardiac responses to obesogenic or high-fructose diets
Authors: Hecker PA, Mapanga RF, Kimar CP, Ribeiro RF, Jr., Brown BH, O'Connell KA, Cox JW, Shekar KC, Asemu G, Essop MF, Stanley WC.
Journal: Am J Physiol Endocrinol Metab (2012): E959
Glucose 6 phosphate dehydrogenase deficiency: a case series
Authors: E, undefined and i Eberle S, Garcia Rosolen N, Urtasun C, Sciuccati G, Diaz L, Savietto V, C and as A, Avalos Gomez V, Cervio C, Bonduel M, Feliu Torres A.
Journal: Arch Argent Pediatr (2011): 354
Glutathione-dependent enzymes and glucose-6-phosphate dehydrogenase of blood in patients with lymphosarcoma (non-Hodgkin's disease)
Authors: Gavriliuk LA, Korchmaru IF, Robu MV, Lysyi LT.
Journal: Biomed Khim (2011): 225
Glucose-6-phosphate dehydrogenase status and severity of malarial anaemia in Nigerian children
Authors: Orimadegun AE, Sodeinde O.
Journal: J Infect Dev Ctries (2011): 792
Implementation and analysis of a pilot in-hospital newborn screening program for glucose-6-phosphate dehydrogenase deficiency in the United States
Authors: Nock ML, Johnson EM, Krugman RR, Di Fiore JM, Fitzgerald S, S and haus LM, Walsh MC.
Journal: J Perinatol (2011): 112